What it is

SS-31 (elamipretide) is a mitochondria-targeted tetrapeptide studied for interactions with cardiolipin and for cellular-energy research. Literature spans cardiac, skeletal-muscle, and neurodegenerative model systems.

Also known as

Elamipretide · Bendavia · MTP-131 · Mitochondrial-targeted peptide

Overview

SS-31 (elamipretide) is a mitochondria-targeted tetrapeptide studied for interactions with cardiolipin and for cellular-energy research. Literature spans cardiac, skeletal-muscle, and neurodegenerative model systems.

Research interest is mitochondrial membrane integrity and ATP-related endpoints under stress. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• Cardiolipin-interaction and mitochondrial-membrane endpoints

• • ATP and cellular-energy markers under stress models

• • Cardiac and skeletal-muscle mitochondrial readouts

•  Oxidative-stress and electron-transport measures where studied

• • Neuro and aging-adjacent mitochondrial research markers

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

Week 1–2: Early mitochondrial and energy-metabolism readouts; compound accumulating in model systems.

Week 3–4: Clearer redox, endurance, or cellular-energy markers in short preclinical windows.

Month 2–3: More pronounced metabolic and cytoprotection endpoints in extended designs.

Month 3–6: Sustained mitochondrial and aging-adjacent observations where studied longer.

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.